Halozyme Therapeutics (HALO) Shareholder's Equity (2010 - 2026)
Halozyme Therapeutics (HALO) Shareholder's Equity (2010 - 2026) Analysis & Trends
Peer Comparison
| # |
Company |
Market Cap |
Enterprise Value |
Gross Profit (Qtr) |
Shareholder's Equity (Qtr) |
| 1 |
Alterity Therapeutics |
814,307.08 Bn |
814,307.05 Bn |
- |
7.14 Bn |
| 2 |
Belite Bio |
55,320.00 Bn |
55,320.00 Bn |
- |
795.79 Mn |
| 3 |
Quantum Biopharma |
17,149.72 Bn |
17,149.72 Bn |
- |
595,226.00 |
| 4 |
Legend Biotech |
3,590.00 Bn |
3,589.71 Bn |
242.10 Mn |
1.00 Bn |
| 5 |
Akari Therapeutics |
1,650.72 Bn |
1,650.72 Bn |
- |
14.38 Mn |
| 6 |
Evaxion A |
1,522.09 Bn |
1,522.07 Bn |
- |
- |
| 7 |
Psyence Biomedical |
229.39 Bn |
229.38 Bn |
- |
- |
| 8 |
Vertex Pharmaceuticals |
113.09 Bn |
105.85 Bn |
2.59 Bn |
19.36 Bn |
| 9 |
Abivax |
90.15 Bn |
90.15 Bn |
- |
502.95 Mn |
| 10 |
Halozyme Therapeutics |
8.24 Bn |
7.92 Bn |
297.47 Mn |
219.64 Mn |
| Date | Value |
|---|
| Mar 31, 2026 |
219.64 Mn |
| Dec 31, 2025 |
48.81 Mn |
| Sep 30, 2025 |
503.92 Mn |
| Jun 30, 2025 |
332.75 Mn |
| Mar 31, 2025 |
482.27 Mn |
| Dec 31, 2024 |
363.82 Mn |
| Sep 30, 2024 |
452.70 Mn |
| Jun 30, 2024 |
289.42 Mn |
| Mar 31, 2024 |
177.81 Mn |
| Dec 31, 2023 |
83.81 Mn |
| Sep 30, 2023 |
249.18 Mn |
| Jun 30, 2023 |
151.03 Mn |
| Mar 31, 2023 |
65.85 Mn |
| Dec 31, 2022 |
169.80 Mn |
| Sep 30, 2022 |
96.99 Mn |
| Jun 30, 2022 |
293.17 Mn |
| Mar 31, 2022 |
260.26 Mn |
| Dec 31, 2021 |
196.95 Mn |
| Sep 30, 2021 |
281.67 Mn |
| Jun 30, 2021 |
119.75 Mn |
